About us 13

Intellectual property excellence and knowledge sharing strategy

At Intravacc, our expertise in vaccine composition and production processes is unparalleled. We continually expand our know-how in this highly competitive field through in-house excellence and knowledge sharing.

Intellectual Property 01

A global and future-proof strategy

To safeguard our innovations and maintain our technological competitive edge, we employ three distinct strategies: 

  • Findings publication: We share our research findings through publications, attracting potential partners in collaborations that acknowledge our expertise. 
  • Trade Secrets: Certain technologies, like our proprietary N. meningitis medium, are kept confidential as valuable trade secrets. Some in-house knowledge is difficult to patent but constitute commercially sensitive information that is important to safeguard. 
  • Patent Protection: We file for patents to secure a 20-year monopoly on ground-breaking technologies. This approach is a gold standard, ensuring freedom to operate and a significant commercial advantage. Our patent portfolio encompasses EU filings plus a global strategy tailored to major markets such as the USA, Canada, India, Japan, China, and Brazil. We focus on protecting our knowledge where it matters most.

Contact us

You can send us an email:
info@intravacc.nl

Reach out to Business Development: 
BD@intravacc.nl

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!

 

Contact form

Subscribe to our newsletter